Amgen Ventures
Overview
As a company formed with venture capital funding more than 25 years ago, Amgen understand the challenges faced by early-stage biotechnology companies. In 2004, they announced the formation of Amgen Ventures, their corporate venture capital fund. With an initial investment of $100 million, the fund is designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics.
Investment Focus
- Innovative biotechnology solutions
- Alignment with Amgen's mission
- Early-stage development
Get the full list of 54,000+ investors
Amgen Ventures and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Amgen Ventures
What sectors does Amgen Ventures invest in?
Amgen Ventures invests in Life Sciences, Digital Health, Biotechnology and Therapeutics, and is based in California, United States. Amgen Ventures is listed as a vc in the ConnectSafely investor database.
What stage does Amgen Ventures invest at?
Amgen Ventures backs companies at Seed, Early Stage, Growth and Late Stage, writing cheques of 2M - 10M.
Which regions does Amgen Ventures invest in?
Amgen Ventures invests across United States, United Kingdom and Europe.
How do I contact Amgen Ventures?
Amgen Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
